162 related articles for article (PubMed ID: 19451137)
1. Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis.
van Tuyl LH; Boers M; Lems WF; Landewé RB; Han H; van der Linden S; van de Laar M; Westhovens R; van Denderen JC; Westedt ML; Peeters AJ; Jacobs P; Huizinga TW; van de Brink H; Dijkmans BA; Voskuyl AE
Ann Rheum Dis; 2010 May; 69(5):807-12. PubMed ID: 19451137
[TBL] [Abstract][Full Text] [Related]
2. Similar efficacy and safety of initial COBRA-light and COBRA therapy in rheumatoid arthritis: 4-year results from the COBRA-light trial.
Konijn NPC; van Tuyl LHD; Boers M; den Uyl D; Ter Wee MM; van der Wijden LKM; Bultink IEM; Kerstens PJSM; Voskuyl AE; van Schaardenburg D; Nurmohamed MT; Lems WF
Rheumatology (Oxford); 2017 Sep; 56(9):1586-1596. PubMed ID: 28859326
[TBL] [Abstract][Full Text] [Related]
3. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention.
Landewé RB; Boers M; Verhoeven AC; Westhovens R; van de Laar MA; Markusse HM; van Denderen JC; Westedt ML; Peeters AJ; Dijkmans BA; Jacobs P; Boonen A; van der Heijde DM; van der Linden S
Arthritis Rheum; 2002 Feb; 46(2):347-56. PubMed ID: 11840436
[TBL] [Abstract][Full Text] [Related]
4. Initial high-dose prednisolone combination therapy using COBRA and COBRA-light in early rheumatoid arthritis.
Rasch LA; van Tuyl LH; Lems WF; Boers M
Neuroimmunomodulation; 2015; 22(1-2):51-6. PubMed ID: 25227967
[TBL] [Abstract][Full Text] [Related]
5. Intensive combination treatment regimens, including prednisolone, are effective in treating patients with early rheumatoid arthritis regardless of additional etanercept: 1-year results of the COBRA-light open-label, randomised, non-inferiority trial.
ter Wee MM; den Uyl D; Boers M; Kerstens P; Nurmohamed M; van Schaardenburg D; Voskuyl AE; Lems WF
Ann Rheum Dis; 2015 Jun; 74(6):1233-40. PubMed ID: 24818633
[TBL] [Abstract][Full Text] [Related]
6. Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis.
Landewé R; Geusens P; Boers M; van der Heijde D; Lems W; te Koppele J; van der Linden S; Garnero P
Arthritis Rheum; 2004 May; 50(5):1390-9. PubMed ID: 15146408
[TBL] [Abstract][Full Text] [Related]
7. Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone.
Korthals-de Bos I; Van Tulder M; Boers M; Verhoeven AC; Adèr HJ; Bibo J; Boonen A; Van Der Linden S
J Rheumatol; 2004 Sep; 31(9):1709-16. PubMed ID: 15338488
[TBL] [Abstract][Full Text] [Related]
8. Normal mortality of the COBRA early rheumatoid arthritis trial cohort after 23 years of follow-up.
Poppelaars PBM; van Tuyl LHD; Boers M
Ann Rheum Dis; 2019 May; 78(5):586-589. PubMed ID: 30808623
[TBL] [Abstract][Full Text] [Related]
9. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.
Boers M; Verhoeven AC; Markusse HM; van de Laar MA; Westhovens R; van Denderen JC; van Zeben D; Dijkmans BA; Peeters AJ; Jacobs P; van den Brink HR; Schouten HJ; van der Heijde DM; Boonen A; van der Linden S
Lancet; 1997 Aug; 350(9074):309-18. PubMed ID: 9251634
[TBL] [Abstract][Full Text] [Related]
10. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial.
Karlsson JA; Neovius M; Nilsson JÅ; Petersson IF; Bratt J; van Vollenhoven RF; Ernestam S; Geborek P
Ann Rheum Dis; 2013 Dec; 72(12):1927-33. PubMed ID: 23196701
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate therapy in rheumatoid arthritis after failure to sulphasalazine: to switch or to add?
Schipper LG; Fransen J; Barrera P; den Broeder AA; Van Riel PL
Rheumatology (Oxford); 2009 Oct; 48(10):1247-53. PubMed ID: 19638454
[TBL] [Abstract][Full Text] [Related]
12. Treatment continuation rate in relation to efficacy and toxicity in long-term therapy with low-dose methotrexate, sulfasalazine, and bucillamine in 1,358 Japanese patients with rheumatoid arthritis.
Nagashima M; Matsuoka T; Saitoh K; Koyama T; Kikuchi O; Yoshino S
Clin Exp Rheumatol; 2006; 24(3):260-7. PubMed ID: 16870092
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness and cost-utility of combination therapy in early rheumatoid arthritis: randomized comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone. COBRA Trial Group. Combinatietherapie Bij Reumatoïde Artritis.
Verhoeven AC; Bibo JC; Boers M; Engel GL; van der Linden S
Br J Rheumatol; 1998 Oct; 37(10):1102-9. PubMed ID: 9825750
[TBL] [Abstract][Full Text] [Related]
14. Why are Dutch rheumatologists reluctant to use the COBRA treatment strategy in early rheumatoid arthritis?
van Tuyl LH; Plass AM; Lems WF; Voskuyl AE; Dijkmans BA; Boers M
Ann Rheum Dis; 2007 Jul; 66(7):974-6. PubMed ID: 17392349
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial.
Verschueren P; De Cock D; Corluy L; Joos R; Langenaken C; Taelman V; Raeman F; Ravelingien I; Vandevyvere K; Lenaerts J; Geens E; Geusens P; Vanhoof J; Durnez A; Remans J; Vander Cruyssen B; Van Essche E; Sileghem A; De Brabanter G; Joly J; Meyfroidt S; Van der Elst K; Westhovens R
Ann Rheum Dis; 2017 Mar; 76(3):511-520. PubMed ID: 27432356
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis suggests that intensive non-biological combination therapy with step-down prednisolone (COBRA strategy) may also 'disconnect' disease activity and damage in rheumatoid arthritis.
Boers M; van Tuyl L; van den Broek M; Kostense PJ; Allaart CF
Ann Rheum Dis; 2013 Mar; 72(3):406-9. PubMed ID: 23155223
[TBL] [Abstract][Full Text] [Related]
17. Discordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis.
van Tuyl LH; Plass AM; Lems WF; Voskuyl AE; Kerstens PJ; Dijkmans BA; Boers M
Rheumatology (Oxford); 2008 Oct; 47(10):1571-6. PubMed ID: 18710900
[TBL] [Abstract][Full Text] [Related]
18. Combination DMARD therapy including corticosteroids in early rheumatoid arthritis.
Möttönen TT; Hannonen PJ; Boers M
Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S59-65. PubMed ID: 10589359
[TBL] [Abstract][Full Text] [Related]
19. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial.
O'Dell JR; Leff R; Paulsen G; Haire C; Mallek J; Eckhoff PJ; Fernandez A; Blakely K; Wees S; Stoner J; Hadley S; Felt J; Palmer W; Waytz P; Churchill M; Klassen L; Moore G
Arthritis Rheum; 2002 May; 46(5):1164-70. PubMed ID: 12115219
[TBL] [Abstract][Full Text] [Related]
20. Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step-up combination therapy (methotrexate, cyclosporin A, sulphasalazine) or monotherapy for three years.
Ferraccioli GF; Gremese E; Tomietto P; Favret G; Damato R; Di Poi E
Rheumatology (Oxford); 2002 Aug; 41(8):892-8. PubMed ID: 12154206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
